Phase II study of tofacitinib (CP‐690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate - Concepedia

Concepedia

Publication | Closed Access

Phase II study of tofacitinib (CP‐690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

295

Citations

17

References

2011

Year

Yoshiya Tanaka, Makoto Suzuki, Hiroyuki Nakamura, Shigeyuki Toyoizumi, Samuel H. Zwillich

Arthritis Care & Research

Abstract

In Japanese patients with active RA with an inadequate response to MTX, tofacitinib in combination with MTX over 12 weeks was efficacious and had a manageable safety profile.

References

	Year	Citations

Page 1